Bruton酪氨酸激酶抑制剂与难治性套细胞淋巴瘤

{"title":"Bruton酪氨酸激酶抑制剂与难治性套细胞淋巴瘤","authors":"Lou An-Qi, Su Qiang","doi":"10.12092/J.ISSN.1009-2501.2021.06.011","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9961,"journal":{"name":"中国临床药理学与治疗学","volume":"26 1","pages":"680"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bruton tyrosine kinase inhibitors and refractory mantle cell lymphoma\",\"authors\":\"Lou An-Qi, Su Qiang\",\"doi\":\"10.12092/J.ISSN.1009-2501.2021.06.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9961,\"journal\":{\"name\":\"中国临床药理学与治疗学\",\"volume\":\"26 1\",\"pages\":\"680\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国临床药理学与治疗学\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.12092/J.ISSN.1009-2501.2021.06.011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国临床药理学与治疗学","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12092/J.ISSN.1009-2501.2021.06.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}